185214 Integration of harm reduction and twelve step approaches to treatment: Oppositional, complementary, or something in-between?

Tuesday, October 28, 2008

Heather Sophia Lee, PhD , Psychiatry, University of California, San Francisco, San Francisco, CA
Harm reduction and twelve step approaches to substance abuse treatment are typically seen as oppositional. However, some harm reduction workers view them as complementary, arguing that Alcoholics Anonymous in its origins was indeed a harm reduction approach as its focus was on “progress not perfection” where “everyone deserves a seat at the table.” This article reports qualitative interview data in which staff members conceptualize the relationship between harm reduction and twelve step approaches to treatment. Data were selected from a study investigating individual participant outcomes of two harm reduction programs: a community-based drop-in center providing case management services to active users who were homeless and another providing individual harm reduction psychotherapy. Face-to-face, qualitative interviews were conducted with 18 staff members and 32 participants of both programs in which outcomes emerged in the areas of demarginalization, consistent engagement in the program, quality of life, social functioning, changes in use, and articulation of future goals and plans.

Learning Objectives:
1.Describe the way in which service providers of harm reduction based treatment think about the integration of harm reduction and twelve step models of treatment. 2.Discuss the way in which harm reduction and twelve step models of treatment are often inaccurately dichotomized and its implications for client treatment needs.

Keywords: Substance Abuse Treatment, Drug Abuse Treatment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I conducted a dissertation on substance abuse treatment, and completed a NIDA-funded postdoc on substance abuse treatment issues.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.